中国药房2024，Vol.35Issue(8)：906-911,6.DOI:10.6039/j.issn.1001-0408.2024.08.02
我国医保谈判药品"双通道"管理政策执行困境及推进策略
Dilemma and promotion strategy of"dual channel"management policy for China's medical insurance negotiated drugs
摘要
Abstract
OBJECTIVE To provide reference for the smooth implementation of the"dual channel"management policy for China's medical insurance negotiated drugs.METHODS Based on Smith policy implementation process model,the dilemmas for the implementation of"dual channel"policy for medical insurance negotiated drugs were analyzed from four aspects:implementation details and regulatory system,drug selection,drug provision and quality control,the situation of medical insurance funds and information technology capabilities.The corresponding promotion strategies were put forward.RESULTS&CONCLUSIONS The"dual channel"policy for medical insurance negotiated drugs in China might face implementation difficulties such as a lack of clear implementation rules and a full process supervision system,the suitability and operability of some medical insurance negotiated drugs need to be considered in the"dual channel"management,difficulties in drug allocation and quality control,differences in the management and operation of medical insurance funds in different regions,and insufficient informatization capability.In this regard,this study suggests that measures,such as improving the implementation rules of the"dual channel"policy,enhancing the rationality of the"dual channel"drug catalog,establishing a dynamic exit mechanism for"dual channel"pharmacies,promoting professional delivery services,and improving the electronic prescription circulation platform,which can be taken to enhance the implementation effect of the"dual channel"policy.关键词
医保谈判药品/双通道/史密斯政策执行过程模型/电子处方流转/冷链运输Key words
medical insurance negotiated drugs/dual channel/Smith policy implementation process model/electronic prescription circulation/cold-chain delivery分类
医药卫生引用本文复制引用
李欣雨,徐娟..我国医保谈判药品"双通道"管理政策执行困境及推进策略[J].中国药房,2024,35(8):906-911,6.基金项目
湖北省医疗保险研究会委托项目(No.H20210183) （No.H20210183）
县级医院科学管理能力提升方案研究项目(No.H20240025) （No.H20240025）
